IP Library Granted Patent US 8,644,920
Granted Patent B2
US 8,644,920 · App. 12/958,423 · Granted Feb 4, 2014

Implantable medical device having magnetic resonance tomography antenna

Inventor: Thomas Doerr (Berlin, DE)
Assignee: Biotronik CRM Patent AG
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,644,920
App. No.
12/958,423
Granted
Feb 4, 2014
Kind
B2
Abstract

The disclosure relates to a device and a method for detecting electromagnetic fields, in particular fields occurring in imaging magnetic resonance tomography.

Claims (32)

1. An implantable medical device (IMD), comprising:

a hermetically sealed housing,

at least one control unit,

at least one power supply,

at least one RF antenna, and

at least one RF communication unit, wherein the RF communication unit in conjunction with the at least one RF antenna are configured to allow communication between an external programming device and the implantable medical device;

at least one frequency diplexer;

a magnetic resonance tomography (MRT) interference detection unit having a demodulation unit, wherein the MRT interference detection unit is connected to

said at least one RF communication unit or

said at least one RF antenna or

said at least one RF communication unit and said at least one RF antenna, by said at least one frequency diplexer;

wherein said demodulation unit is configured to detect RF rotary fields typical of MRT and transmit an MRT detection signal from the MRT detection unit to the at least one control unit; and,

wherein the MRT interference detection unit is additionally connected or connectable via one of said at least one frequency diplexer to an electrode line that is present, and wherein the demodulation unit is configured to detect the MRT only when RF rotary fields are simultaneously detected via the at least one RF antenna and via the electrode line.

2. The IMD according to claim 1 , wherein the at least one RF antenna is configured to communicate in a medical implant communication service (MICS) frequency band.

3. The IMD according to claim 1 , wherein the at least one RF antenna is configured to communicate in at least one of an industrial, scientific, and medical (ISM) band.

4. The IMD according to claim 1 , wherein the demodulation unit is configured to detect the MRT based on an evaluation of a frequency spectrum typical for that MRT, that occurs at the at least one RF antenna.

5. The IMD according to claim 1 , wherein the at least one RF antenna has maxima in three spatial directions, preferably in three orthogonal spatial directions.

6. The IMD according to claim 1 , wherein the IMD is switched to an MRT safe state when the MRT interference detection unit has detected an MRT field, and the MRT-safe state has ventricular fibrillation (VF) detection which may be prolonged by a predetermined period of time.

7. The IMD according to claim 1 , wherein the MRT interference detection unit is further connected to indicators configured to indicate MRT interference fields or to at least one MRT sensor.

8. The IMD according to claim 1 , wherein the at least one control unit is configured, in case of MRT electromagnetic field detection, to:

change to an MRI-safe state;

remain for a prolonged period of time in an MRI-safe state;

remain for a prolonged period of time in a state that is otherwise insensitive to electromagnetic interference fields;

synchronize electrical measurements with field intensity minimum values that occur with periodic or pulsed electromagnetic fields;

synchronize a stimulation using the minimum values; or

emit electromagnetic pulses configured to signal that a medical device, or an implant, is present in the MRT electromagnetic field.

9. The IMD according to claim 1 , wherein a change is made to an MRT safe state when a field typical of the MRT is detected, this state being either permanent until a possible reprogramming, or temporary for a specified period of time, or being maintained until no MRT is detected or until there is no MRT is detected for a specified period of time.

10. The IMD according to claim 9 , wherein the IMD is an implantable stimulator, cardiac pacemaker, ICD (implanted cardioverter/defibrillator), or neurostimulator, and the MRT-safe state has a fixed stimulation rate, or a specified or predetermined stimulation characteristic, and/or the delivery of high-energy stimuli is inhibited for the ICD, and/or tachycardial detection is inhibited.

11. The IMD according to claim 1 , wherein the MRT interference detection unit performs MRT detection only before or during charging of a high-voltage capacitor.

12. The IMD according to claim 11 , wherein during the MRT detection, the at least one RF antenna is tuned to one or more RF frequencies that are typical of the MRT , in order to specify either a fixed frequency or to sample a frequency range.

13. The IMD according to claim 12 , wherein the sample of the frequency range comprises a sample of one or more frequency ranges and is carried out using a band pass filter.

14. The IMD according to claim 11 , wherein different predetermined MRT-safe states are automatically selected for MRT devices which operate at different magnetic field intensities and thus different RF frequencies.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 23, 2018
From: BIOTRONIK CRM PATENT AG
To: BIOTRONIK SE & CO. KG
Reel/Frame 045995/0948 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 2, 2010
From: DOERR, THOMAS
To: BIOTRONIK CRM PATENT AG
Reel/Frame 025436/0143 →
Continuity (2)
Provisional Application 61288854 · Dec 22, 2009
Related Publication 20110152674A1 · Jun 23, 2011